EC Number |
Inhibitors |
Structure |
---|
2.7.1.130 | 5-amino-1-(3,4-dimethoxyphenyl)-1H-1,2,3-triazole-4-carboxamide |
- |
|
2.7.1.130 | 5-amino-1-(3-chloro-4-methoxyphenyl)-1H-1,2,3-triazole-4-carboxamide |
- |
|
2.7.1.130 | 5-amino-1-(3-chlorophenyl)-1H-1,2,3-triazole-4-carboxamide |
- |
|
2.7.1.130 | 5-amino-1-(4-bromophenyl)-1H-1,2,3-triazole-4-carboxamide |
- |
|
2.7.1.130 | 5-amino-1-(4-ethoxyphenyl)-1H-1,2,3-triazole-4-carboxamide |
- |
|
2.7.1.130 | Ca2+ |
- |
|
2.7.1.130 | Cu2+ |
- |
|
2.7.1.130 | Fe3+ |
- |
|
2.7.1.130 | more |
comparative metabolic pathway analysis (Metacyc), data mining from a database of essential genes (DEG), homology modeling, molecular docking, pharmacophore based virtual screening, ADMET prediction and molecular dynamics simulation are used to identify compounds as potential enzyme inhibitor drugs |
|
2.7.1.130 | Ni2+ |
- |
|